| Issues in massive transfusion settings |
|
|
|
|
|
|
|
|
|
|
|
|
|
| n | Haemostatic
defects |
|||||||||||
| n | “Unknown”
patients |
|||||||||||
| n | Appropriateness
of usage - especially of non-red cell |
|||||||||||
| support |
||||||||||||
| n | Stocks /
Inventory management |
|||||||||||
| n | Communication |
|||||||||||
| n | Rapid
performance of investigations & compatibility |
|||||||||||
| tests |
||||||||||||
| n | Rapid issue of
blood products |
|||||||||||
| n | Haematological
advice/consultation |
|||||||||||
| n | Documentation |
|||||||||||